Can-Fite BioPharma Ltd. (TASE:CANF) Financings

Can-Fite BioPharma Ltd.

Financings

RaiseDate
Warrant exercise of american Depositary Shares upon exercise of warrants
Announced: about US$4M · US$5 a share · Warrants at US$5 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Research and development, clinical trials, working capital and general corporate purposes
Mar 4, 2026
Public offering of american Depositary Shares (or pre-funded warrants) with short-term warrants
Announced: about US$5M · US$0.6 a share · Warrants at US$0.6 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Research and development, clinical trials, working capital and general corporate purposes
Jul 28, 2025
Registered direct offering of american Depositary Shares
Announced: US$3M · US$1.2 a share · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Research and development, clinical trials, working capital and general corporate purposes
Apr 14, 2025

Read by 6ix AI from the company's releases